Overview
No overview information available.
Indication
利福平、异烟肼、吡嗪酰胺、乙胺丁醇复方制剂适用于结核病的初治和复治（非耐多药性）。结核病患者的2～3个月强化期治疗；而利福平、异烟肼复方制剂适合于上述病人的4～6个月维持期治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ethambutol Hydrochloride,Pyrazinamide,Rifampicin and Isoniazid Tablets(Ⅱ) | 国药准字H20110094 | 化学药品 | 片剂 | 1/18/2021 | |
| Ethambutol Hydrochloride,Pyrazinamide,Rifampicin and Isoniazid Tablets(Ⅱ) | 国药准字H20051903 | 化学药品 | 片剂 | 5/9/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.